Geneious Biologics presents at conference in San Diego

Geneious Biologics presents at Antibody Engineering & Therapeutics conference in San Diego

AUCKLAND, NZ – November 29, 2017 – Biomatters Vice President of Technology Services, Jannick Bendtsen, PhD, will present at the Antibody Engineering & Therapeutics conference on December 13, at the Manchester Grand Hyatt in San Diego, CA.

Dr Bendtsen is the development leader of Geneious Biologics, an enterprise software as a service (SaaS) solution for screening antibodies and antibody-like constructs created by Biomatters, and will deliver a scientific briefing titled Scalable Sequence Data Analysis for Accelerated Precision Antibody Discovery.

His talk will examine how next-generation sequencing (NGS) technologies will provide the ability to comprehensively characterize and evaluate the diversity and quality of antibody libraries, accelerating identification of potential drug candidates.

Scientific Briefing: Scalable Sequence Data Analysis for Accelerated Precision Antibody Discovery
Presenter: Jannick Bendtsen, PhD, Vice President of Technology Services, Biomatters
Event: Antibody Engineering & Therapeutics
Location: Manchester Grand Hyatt, San Diego
Date: 13 December 2017
Time: 1:45 PM (PT), Hillcrest Room

ends

© Scoop Media